The hottest summer Ai Ye Zheng Qi is not selling well, chongqing taiji industry's Q3 performance has dropped by 70%|interpretations

In 2024, the national average temperature is the highest in the same period since 1961, but the sales volume of chongqing taiji industry Huoxiang Zhengqi Oral Liquid in the third quarter has significantly decreased, with a sharp drop in large single product sales, resulting in more than a 70% year-on-year decrease in chongqing taiji industry's third-quarter profit.

cls.cnOct 24 21:59

Shijiazhuang Yiling Pharmaceutical: The performance of respiratory products is affected by the high base in previous years and the high inventory in hospitals, related sales will gradually return to normal | Directly targeting the earnings conference

①Due to factors such as the high base number of the previous year and the high social inventory, which led to a decrease in market demand, respiratory products were affected, resulting in a decline in performance. In the future, the company's sales of respiratory products will gradually return to normal. ② The company expects that both the cardiovascular and cerebrovascular block order products, as well as the secondary products like Bazibu Shen, anxiety relief, etc., have good market potential. The future performance of respiratory system new products is also promising, and the company will continue to build a core product cluster.

cls.cnOct 15 23:13

Huadong Medicine targets 'Suyan Zhen' infringement! What is the purpose of the two 'Girl's Needles' fighting each other across space?

①Huadong Medicine's "Iyan Shi" claims that Caicai Medical's "Suyan Zhen" infringes on its invention patent rights, and has now filed a civil lawsuit; ② Caicai Medical's parent company Guyu Chun denied this statement, and as of now, the market launch of "Suyan Zhen" is less than two months old; ③ Industry insiders believe that it is difficult to determine whether Guyu Chun has engaged in infringement at this time.

cls.cnOct 12 20:24

Long-serving senior executive of lepu medical technology resigns, can the second generation successor stop the decline in performance? | Express announcement

①Tonight, lepu medical technology announced the resignation of General Manager Zhang Zhibin and Deputy General Manager Zheng Guorui, with Chairman's daughter Pu Fei taking over as General Manager, who has a background of "sea turtle elite"; ②Starting from 2023, lepu medical technology's performance has declined for several consecutive quarters, with market cap dropping by a quarter compared to the peak period.

cls.cnSep 25 23:34

CP smart home AI health services will be launched this year. Guangxi Liuyao Group: The new online settlement policy is conducive to improving the current high accounts receivable situation. | Direct hit earnings conference

At the earnings conference, Chairman Zhu Chaoyang of Guangxi Liuyao Group introduced the progress of the company's AI scenario application business. For the high accounts receivable, the company's CFO Zeng Xiangxing stated that the company has adjusted its operational strategy and strengthened the collection efforts. Guangxi Liuyao Group also responded to the slight decline in growth of the pharmaceutical wholesale sector and issues related to the expansion of pharmaceutical new retail business.

cls.cnSep 11 20:30

A subsidiary has been "blacklisted" by Shenzhen for one year. Jointown Pharmaceutical Group claims to be "in the process of defending". The industry believes that the intensity of procurement supervision is continuously increasing.

Recently, Jointown Pharmaceutical Group's subsidiary, Jointown Medical Device, was fined and banned from participating in Shenzhen procurement for one year due to providing false information in a tender at a hospital in Shenzhen. Jointown Pharmaceutical Group responded to a reporter from Caijing.com.cn, stating that this incident is a pending matter, and they have organized appeal materials and are currently undergoing administrative reconsideration. This year, several listed companies have been fined for violations in the bidding and procurement process, leading industry insiders to suggest that companies should pay more attention to compliance with details during the bidding process.

cls.cnSep 6 17:24